News

Hydrogen and methane breath testing (HMBT) is a non-invasive diagnostic tool frequently used to assess small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption disorders such as lactose and fructose intolerance. Despite its widespread use in adults, its application in children...

Bedfont® Scientific Limited partners with Selig De Colombia to bring the Gastrolyzer® range of HMBT devices to Colombia. Bedfont® Scientific Limited, word leaders in breath analysis with over 48 years of knowledge and expertise in designing and manufacturing innovative medical...

In November 2024, the British Thoracic Society (BTS), Scottish Intercollegiate Guidelines Network (SIGN), and the National Institute of Care Excellence (NICE) asthma guidelines1 were released superseding the previously separate guidelines from BTS/SIGN2 and NICE3. The new joint guideline, based on...

Following a summer of community engagement in the Shaun in the Heart of Kent art trail; Bedfont® awards a prize for finding ‘Shorn the Return’. Bedfont® Scientific Ltd., a world leader in breath analysis with over 47 years of expertise...

Double Victory for Bedfont®: Crowned ‘Medium Business of the Year 2024 and ‘Best of Kent’. Bedfont®, located in Harrietsham, Kent, has over 48 years of expertise in designing and manufacturing medical breath analysis devices. Bedfont® was delighted to win Medium...

Hydrogen-methane breath testing (HMBT) is a widely used, non-invasive method to diagnose conditions such as small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption (e.g. lactose intolerance). The accuracy of HMBT results depends heavily on proper quality controls, accurate calibration, appropriate...